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The effects ofa single treatnlent ofan acaricide, Acarosan,
and a detergent, Metsan, on Der p 1 allergen levels in the
carpets and mattresses ofasthmatic children
A. MANJRA, D. BERMAN, A. TOERIEN, E. G. WEIl\TBERG, P. C. POTTER
Abstract Baseline levels of the house-dust ll1ite allergen,
Der pi, were ll1easured on the carpets and ll1at-
tresses of 60 pure-=ite-sensitive asth=atic child-
ren in the Cape Peninsula, by ll1eans of an
enzYll1e-linked iIIlIIlunosorbent assay (ELISA).
High levels of =ite allergens were recorded (range
2 - 50 jJ.g Der p 1/g dust). In order to investigate
the efficacy of the application of acaricides to car-
pets and bedding, 3 groups of 20 children were
studied. Carpets and ll1attresses in group A were
treated with a detergent, Metsan (Snowchell1),
and in group B with Metsan cOll1bined with the
acaricide, Acarosan (Noristan). ·Group C was a
control group in which no treatll1ent was applied.
The level of airway hyperreactivity (PC20) to his-
ta=ine was ll1easured at the beginning of the study
and again 3 ll10nths after acaricide treatll1ent.
Significant reductions in carpet Der p 1 levels
were achieved in group A (22,83 v. 13,26 jJ.g Der p
1/g dust; P =0,04) and group B (21,76 v. 13,26 j..Lg
Der p 1/g dust; P =0,01), but =ite levels were not
reduced in any of the ll1anresses treated. There
was also no i=provell1ent in airway hyperreacti-
vity in any of the groups.
This study clearly dell10nstrates that at present
it is not possible to reduce Der p 1 antigen levels in
ll1attresses in the Cape Peninsula with the avail-
able acaricides, even when one of these is COIn-
bined with a detergent solution.
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Until strategies are developed which will signi-
ficandy reduce Der p 1 levels in the bedding of
sensitive individuals, a reduction in ongoing air-
way inflatnll1ation and airway hyperreactivity can-
not be expected.
S Atr Med J 1994; 84: 278·280.
~
ergy to house-dust mites occurs in 67 - 80% of
children with allergic disease in the Cape Penin-
sula. I•2 Chronic exposure to perennial allergens,
such as the house-dust mite, results in an inflammatory
process in the airways3" which in turn increases the air-
way nonspecific reactiviry to cold air, exercise, tobacco
smoke and specific allergen challenge. Mite-allergic
asthmatic patients, when placed in a mite-free environ-
ment, experience a significant reduction in nonspecific
bronchial hyperreactivity and in their symptoms.'
Furthermore, their requirements for anti-inflammatory
treannent with steroids or cromoglycate are reduced.
Although it has been known since 1955 that house-
dust mites are found in the coastal regions of South
Africa," immunochemical determination of the allergen
level of house-dust mite, Dermawphagoides pceronyssinus
(Der pi), has not previously been undertaken. The
recent availability of such assays for Der pI antigen' has
made it possible to quantify and evaluate objectively the
protocols currendy recommended to reduce house-dust
mite levels in patients' homes.
Several acaricides have been found to kill mites effec-
tively under laboratory conditions.' Their acaricidal
effects on mites in patients' homes are influenced by
factors such as the age of the house, the level of mite
infestation, the ambient humidity and temperature, the
presence or absence of carpets and the nutrient supply
for the mites.
We report the results of a prospective study which
documents the levels of Der p I in the carpets and
Results
TABLE I.
Mean levels of Der p 1 (/lg!g dust)
and I),-agonisrs, antihistamines and sodium cromogly-
care were continued for 3 days.
Carpet Mattress



































Histamine challenge tests (median values PC20 (/lmol»
Baseline 3-month 2 dilution Signed rank
PC20 PC20 shift test
Statistical analysis
Analysis of the dara was underraken by rhe Sourh
African Medical Research Council, Paro\Vvallei, CP; the
Mann-Whirney U-resr and the signed rank resr were
used.
Permission ro perform the study was obrained from
the Ethics and Research Commirree of rhe Medical
School of the Universiry of Cape Town, and informed
consem was obrained from the parems of the children in
the study.
Results of the hisrarnine challenge resrs are shown in
Table IT. Baseline median PC20 levels were not signifi-
cantly different in the 3 groups. There was no irnprove-
mem in the hisramine sensitiviry of any of the groups at
3 months. In fact, both groups B and C showed a signi-
ficant deterioration in their bronchial hyperreactiviry ro
histamine (signed rank tesr: group B - P = 0,02; group
C-P= 0,05).
Fifty-nine patiems complered the study. There was no
significant difference berween groups A, Band C in
respecr of age and sex distriburion. The mean age of the
children was 9,6 years.
Mean baseline Der p 1 levels were above 22,8 fl-g/g
dust in group A, 21,7 fl-g/g dusr in group Band 16,65
fl-g/g dust in group C. Although the mean baseline
Der p 1 level on the carpets was apparently lower in
the control group, the difference was nor significanr.
Baseline Der p 1 levels on the mattresses were markedly
higher than on the carpers in all 3 groups.
Three months after application of Mersan or Metsan
plus Acarosan, a significanr reduction in baseline Der p
1 levels on the carpets was observed in groups A (P =
0,04) and B (P = 0,01) bur nor in the control group C
(Table I). There was no significanr reduction in the level
of Der p 1 antigens in the mattresses 3 months after
application of the Metsan or Mersan plus Acarosan.
This is the fusr study in Africa in which Der p 1 antigen
levels have been recorded by means of an EUSA. Our
studies have shown thar levels of the house-dusr mire,
Patients
Sixry children berween the ages of 5 and 12 years were
studied. The children were known asthmatics, familiar
with the use of a peak flow merer, or Virallograph.
All children had strongly positive skin tests or radio-
allergosorbent tests (RASTs) for house-dust mire (Der
p 1) and negative RASTs or skin tesrs for other aero-
allergens (including fungi, dogs, cats, feathers, grass and
tree pollens). All patients lived in the Cape Peninsula.
Patients were matched according to age, asthma treat-
ment and sex and then randomised via a system of ran-
dom numbers into 3 groups of 20 patients, A, B and C.
None of the children had any history of recurrem bron-
chitis and none of them was a smoker. None of the
patients was on oral steroids. Several were on inhaled
steroids and these were evenly spread among the mem-
bers of the 3 groups when they were matched for treat-
ment and severiry.
mattresses of 60 asthmatic children in Cape Town and
evaluates the efficacy of an acaricide, containing benzyl
benzoate (Acarosan; Toristan), and a detergenr
(Metsan; Snowchem), in reducing Der p 1 levels 3
months after a single application.
Histamine challenge
Histamine challenges were conducted on all parients
according to the method of Yan er al." and the PC20
was calculated by means of a linear algebraic formula. lo
A baseline hisramine level of PC20 was determined
before the application of Metsan or Acarosan, and again
at 3 months. Before bronchial challenge tesrs were con-
ducred, inhaled steroids were discontinued for 1 week
Application of acaricides
Acarosan or Metsan was applied to the carpets or
mattresses (60 glm') after baseline dusr samples were
collected. Group A patients had their carpers and mar~
tresses rreared with Metsan. Group B had theirs rreared
with a combination of Mersan arid Acarosan, and group
C's underwem no treatment.
Mersan is a water-based mixture of alcohol, derer-
gems and antimicrobial substances (mainly fungicides)
in an amino plastic foam carrier, and is available ar local
supermarkets as a foam and powder formularion for
application ro mattresses and carpers respecrively.
Acarosan foam comains benzyl benzoare, methacrylare
copolymerisare, rensides (sodium lauryl sulphare and
olepine sulphare), fatty acids, sodium hydroxide, 1,2
benzisorhiazoline, propane/butane and water. The
powder also contains cellulose, paraffin, sodium alumi-
nium silicare and silicone dioxide.
Der p 1 analysis
Baseline dust samples were collecred from the carpers
and mattresses in the children's bedrooms with a Vorwerk
vacuum cleaner fined with a paper bag. An area of 1 m'
of the floor beside the bed and 2 m' of the upper surface
of the mattress was vacuumed for 2 minures and the
dusr sample sieved through a 0,3 mm mesh to obtain
fine dusr. The dust was stored at -20°C until extracted
with borate-buffered saline. Dusr samples were collected
again after 3 months and Der p I levels derermined by
EUSA according to the method ofLuczynska er aP (i.e.
wirh the monoclonal antibody clone 5HS C12D9;






Der p 1 in the Cape Peninsula were uniformly much
higher than the levels regarded as safe for asthmatics
(i.e. < 2 IJ.g/g dust) in the homes of all the children
·studied. The range of allergen levels we observed is
similar to elevated levels reponed from Brazil and
Sydney, Australia," but are higher than those reported
by Sporik el al. 12 in the UK.
Our study has shown that a single application of
Metsan significantly reduced Der p 1 levels in carpets
and that this reduction was further improved by the
addition of Acarosan. This is, to our knowledge, the first
study in which the enhancing effect of a detergent
(Metsan) on Der p 1 reduction by an acaricide has been
demonstrated in carpets, and this has practical implica-
tions for mite control in carpets. Disappointingly, we
did not significantly reduce mite allergen levels on the
patients' beds. We also failed to demonstrate any
improvement in the bronchial hyperreactiviry in any of
the asthmatic children srudied.
Failure to achieve a significant reduction in Der p 1
levels in the bedding has recently been alluded to by
others. 13 There may be several reasons for this. In the
first instance, the mattresses probably contain a large
reservoir of accumulated Der p 1 allergens from the
faecal pellets of mites which cannot be removed by
vacuuming; secondly, it is probably also necessary to
treat bed covers, duvets and pillows with acaricides to
remove the live mites which would recolonise the mat-
tresses.
Although we achieved a statistically significant reduc-
tion in Der p 1 levels in the carpets, they were not
reduced to a level which would prevent further allergic
sensitisation. A recent study suggests that an application
of Acarosan for 12 hours instead of the manufacturer's
recommended 4 - 6 hours may be more effective in
reducing mite population in carpets. 14
The lack of clinical benefit in this srudy from acari-
cides, which are highly effective in the laboratory, is
disappointing. In order to improve the efficacy of the
acaricides it is probably necessary to treat the entire
house (in addition to the bedroom), and to use addi-
tional measures which do not favour recolonisation or
proliferation of the mites, such as reduction of the
humidity to less than 50% with air-conditioning sys-
tems, or the application of liquid nitrogen. These mea-
sures are unfortunately expensive and not practicable for
most of our patients.
A two-fold deterioration in the PC20 values in
groups B and C was observed. Deterioration occurred
in the control group as well as a test group. Our srudy
was conducted during the winter months and the appar-
ent deterioration in PC20 values may reflect the worsen-
ing of the overall clinical starus which we often observe
in our asthmatic patients in the winter months, when
intercurrent viral infections are common. Furthermore,
without a significant reduction in mattress levels of Der
p 1, a deterioration in PC20 is hardly unexpected, since
airway inflammation and hyperreactiviry are likely to
deteriorate in the presence of ongoing allergen exposure.
Our srudies confirm that both Metsan and Acarosan
are useful reagents for reducing house-dust mite levels
in carpets. Six-monthly applications are recommended
by the manufacturers. It is likely that more frequent and
longer applications of these substances would further
reduce the Der p 1 levels in carpets, but complete
removal of carpets would be best for patients.
Our srudy clearly shows how difficult it is to elimi-
nate mites from bed mattresses in a coastal ciry like
Cape Town, and emphasises the futiliry of simply treat-
ing mattresses with the acaricides on the market without
checking to see if one has achieved a reduction in the
allergen level. The failure to achieve any reduction in
mite levels on bedding indicates that alternative strate-
gies must be sought. Bed covers, duvets, pillows and
soft toys present an often unrecognised source of mites
and these should be removed or hot-washed often.
Recent evidence suggests that plastic-coated mattress
covers may prevent mite faecal pellets, produced by
colonies deep within the fabric of the mattress, from
being inhaled by the patients.
Until mite control measures achieve significant
reductions of Der p 1 allergens in bedding, an improve-
ment in the bronchial hyperreactiviry and clinical starus
of the patients cannot be expected. Strategies directed
specifically at mite control in the bedding need to be
explored in the future.
The authors wish to mank Mr K. Kau of Snowchem
(Pry) Ltd for a financial grant to the Allergy Society of
South Africa to purchase the reagents for the Der p 1
assays, Mr Tony Cawood of Vorwerk for assistance wim
collection of me dust samples, Miss Jane Hall of the MRC,
Cape TO\vn, for assistance with the statistical analysis of me
data and Dr Pat Ireland for valuable advice.
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